SUBSCRIBE
SUBSCRIBE
News   Business

Angel Biotechnology Ltd Signs 450,000 stg Contract with Russia’s Materia

July 6, 2007 | 
1 min read

LONDON (Thomson Financial) - Angel Biotechnology Holdings PLC said it has signed a contract worth about 450,000 stg with Russia-based Materia Medica Holdings for process development and GMP manufacture of polyclonal antibodies.

Alliances Europe
MORE ON THIS TOPIC
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Cellectar Downsizes by 60% as it Explores Strategic Options for Cancer Drug
December 11, 2024
 · 
202 min read
 · 
BioSpace Editorial Staff
Sign outside BioNTech's building in Germany
Breast cancer
BioNTech Builds Case for PD-L1/VEGF Bispecific With Promising Breast Cancer Data
December 11, 2024
 · 
2 min read
 · 
Tristan Manalac
Podcast
Highlights From ASH, Lilly and Novo’s Manufacturing Boon, Momentum in Neuro, More
December 11, 2024
 · 
1 min read
 · 
Heather McKenzie
Group Of Employees Being Fired By Their Company.
Layoffs
Carisma Therapeutics to Cut 34% of Staff, Reprioritize Pipeline
December 10, 2024
 · 
2 min read
 · 
Angela Gabriel